An interventional study of Quranic Recitation (Murottal) in Psychosomatic Symptoms and Fatigue Symptom, sponsored by Universitas Indonesia. Completed at 1 site in Indonesia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-22.
Sponsored by Universitas Indonesia · Not applicable, Interventional, and Treatment
This randomized controlled trial evaluates the effect of Quranic recitation (murottal) on psychosomatic symptoms and fatigue in adults living with HIV who have psychosomatic symptoms and fatigue. Participants are randomly assigned to either the intervention group, which receives Quranic recitation for approximately 15 minutes, three times per week for 30 days, or the control group. Psychosomatic symptoms and fatigue are assessed before and after the intervention using the Shatri-Sinulingga Psychosomatic Test (SSPT) and Fatigue Severity Scale (FSS), respectively.
Adults aged ≥18 years. Diagnosed with human immunodeficiency virus (HIV) infection. Muslim. HIV clinical stage 1-2. Undetectable HIV viral load. Shatri-Sinulingga Psychosomatic Test (SSPT) score ≥2. Fatigue Severity Scale (FSS) score ≥36. Willing to participate in the study and provide informed consent.
Exclusion Criteria:
Severe hearing impairment or inability to follow the intervention procedure. Psychotic disorder or depressive disorder requiring psychiatric medication. Pregnancy. Active opportunistic infection. Refusal to participate in the study.
15 mins/ 3 times a week for 30 days
Behavioral: Quranic Recitation (Murottal)
Standard care without murottal intervention
Participants receive Quranic recitation (murottal) for approximately 15 minutes, three times per week for 30 days (12 sessions).
Change in Shatri-Sinulingga Psychosomatic Test (SSPT) Score
Time frame: Baseline to 30 days after randomization
Change in Fatigue Severity Scale (FSS) Score
Time frame: Baseline to 30 days after randomization
Plan to share: No
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitas Indonesia